|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 751-756, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
D Marelli, A Paul, R Samson, D Edgell, P Angood and RC Chiu
Colloid solution is commonly used to increase the oncotic pressures of
priming solutions used in the cardiopulmonary bypass circuit. To study the
effectiveness of this practice, we prospectively randomized 100 adult
patients undergoing cardiac operations to receive Ringer's lactate solution
plus 50 gm of albumin (group A) or Ringer's lactate solution alone (group
B) as the prime solution for the bypass circuit. Personnel involved in the
management of these patients were blinded concerning the group to which the
patients had been randomized. Forty clinical parameters related to
perioperative fluid balance, cardiopulmonary function, and renal function
were studied. Although group B received a larger volume of crystalloid
solution intraoperatively (p less than 0.05), had a lower mean cardiac
filling pressure (p less than 0.05), and had a higher hematocrit value (p
less than 0.05) in the immediate postoperative period, all mean values for
both groups were within the normal range. There were no differences between
the two groups with regard to postoperative clinical parameters of
cardiopulmonary and renal function, nor was outcome affected by the
addition of albumin to the prime solution. We conclude that there is no
clinically detectable advantage for the practice of adding 50 gm of albumin
to the priming solution of bypass circuits in adults undergoing cardiac
operations. Routinely supplementing the bypass prime solution with albumin
adds significant cost, estimated to be approximately $10,000 per 100 cases,
without demonstrable clinical benefits. Whether this practice can be of
value in selected cases needs to be further studied.
ARTICLES
Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome? A prospective randomized study
Department of Surgery, Montreal General Hospital/McGill University, Quebec Canada.
This article has been cited by other articles:
![]() |
J. W. Hammon Extracorporeal Circulation: Perfusion System Card. Surg. Adult, January 1, 2008; 3(2008): 350 - 370. [Full Text] |
||||
![]() |
E. A. Hessel II and L. H. Edmunds Jr. Extracorporeal Circulation: Perfusion Systems Card. Surg. Adult, January 1, 2003; 2(2003): 317 - 338. [Full Text] |
||||
![]() |
M. M. Wilkes and R. J. Navickis Patient Survival after Human Albumin Administration: A Meta-Analysis of Randomized, Controlled Trials Ann Intern Med, August 7, 2001; 135(3): 149 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Scott, P.J. Hore, J. Cannata, K. Mason, B. Treagus, and J. Mullaly A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery Perfusion, November 1, 1995; 10(6): 415 - 424. [Abstract] [PDF] |
||||
![]() |
I. R Jenkins and A. P Curtis The combination of mannitol and albumin in the priming solution reduces positive intraoperative fluid balance during cardiopulmonary bypass Perfusion, September 1, 1995; 10(5): 301 - 305. [Abstract] [PDF] |
||||
![]() |
G. E. Hastings and P. G. Wolf The Therapeutic Use of Albumin Arch Fam Med, November 1, 1992; 1(2): 281 - 287. [Abstract] [PDF] |
||||
![]() |
L. Sandrelli, O. Alfieri II, and W. van Oeveren The problem of priming solutions? The solution of priming problems Perfusion, July 1, 1992; 7(3): 217 - 221. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |